Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0600
-0.0010 (-1.64%)
At close: Jan 9, 2026
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 24.21 million as of January 9, 2026. Its market cap has increased by 70.12% in one year.
Market Cap
24.21M
Enterprise Value
23.97M
Revenue
6.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 24.21M, a decrease of -75.38%. That is a compound annual growth rate of -24.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 24.21M | -1.64% |
| Dec 31, 2025 | 24.61M | 62.80% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 81.96B |
| Pro Medicus | 22.46B |
| Cochlear | 17.17B |
| Sonic Healthcare | 10.94B |
| Ramsay Health Care | 8.20B |
| Ansell | 5.07B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |